$AXXE We pride ourselves in providing cost-effective therapeutic options for patients, especially in underserved disease segments.
Over the Counter and prescription products will be introduced in Canada and other countries. Prescription products will consist of specialized medicines with few competitors.
Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.
Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE . Headquartered in Canada, AXXE is a specialty pharmaceutical and nutritional supplements company, that works through its wholly owned subsidiary, AllStar Health Brands Inc.
